Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 9/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 2/20 | 0.39 |
| ▸ | NOS2 | P35228 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL4593968 | 1.00 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Bromide SCHEMBL11815034 | 1.00 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Bromide SCHEMBL128888 | 1.00 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL33509 | 0.97 | CYP3A4 (0.50) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Water SCHEMBL35583 | 0.94 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Iodide SCHEMBL1157672 | 0.94 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Fluoride SCHEMBL1502751 | 0.94 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Water SCHEMBL9259705 | 0.94 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| Hydrochloric Acid SCHEMBL553599 | 0.94 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 | |
| SCHEMBL15346025 | 0.94 | CYP3A4 (0.48) | CYP3A4TSHRPIK3CAALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 497 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120049017-A | Org/ZnSO4Electrolyte, preparation method thereof and application of electrolyte in secondary battery | 同济大学 | 2025-05-27 | — | — | CN | claimed |
| US-20240279551-A1 | LIQUID CRYSTAL EMULSIONS AND USES THEREOF | CORNELL UNIVERSITY | 2024-08-22 | — | — | US | claimed |
| WO-2023283010-A2 | LIQUID CRYSTAL EMULSIONS AND USES THEREOF | CORNELL UNIVERSITY (US) | 2023-01-12 | — | — | WO | claimed |
| WO-2020159007-A1 | METHOD FOR PREPARING ACYLOXYBENZENESULFONATE COMPOUND | 주식회사 비제이바이오켐 | 2020-08-06 | — | — | WO | claimed |
| US-20110224458-A1 | PREPARATION OF METHIONINE OR SELENOMETHIONINE FROM HOMOSERINE VIA A 4-SUBSTITUTED 2-AMINOBUTANOIC ACID INTERMEDIATE | NOVUS INTERNATIONAL INC. (US) | 2011-09-15 | — | — | US | claimed |
| US-7635662-B2 | Compound for color-producing composition, and recording material | CHEMIPRO KASEI KAISHA, LTD. (JP) | 2009-12-22 | — | — | US | claimed |
| EP-0821268-B1 | An emulsion for a photothermographic material, a production process for the photothermographic material and a recording process therefor | AGFA GEVAERT (BE) | 2004-04-07 | — | — | EP | claimed |
| US-6383725-B2 | ORGANIC SILVER SALT, PHOTOSENSITIVE SILVER HALIDE AND CATALYST | AGFA-GEVAERT (BE) | 2002-05-07 | — | — | US | claimed |
| US-20010028996-A1 | Emulsion for a photothermographic material, a production process for the thermographic material and a recording process therefor | AGFA GEVAERT | 2001-10-11 | — | — | US | claimed |
| US-6187516-B1 | LIGHT-INSENSITIVE ORGANIC SILVER SALT, PHOTOSENSITIVE SILVER HALIDE; SILVER SALT; BINDER; TETRAMETHYLAMMONIUM CHLORIDE PERBROMIDE, TRIMETHYLPHENYLAMMONIUM BROMIDE PERBROMIDE OR TETRAMETHYLAMMONIUM BROMIDE | AGFA-GEVAERT (BE) | 2001-02-13 | — | — | US | claimed |
| EP-0821268-A1 | An emulsion for a photothermographic material, a production process for the photothermographic material and a recording process therefor | AGFA-GEVAERT N.V. (BE) | 1998-01-28 | — | — | EP | claimed |
| EP-0010843-B1 | METHOD OF MAKING 5,6-DIHYDRO-2-METHYL-N-PHENYL-1,4-OXATHIIN-3-CARBOXAMIDE | UNIROYAL LTD. (CA) | 1983-11-09 | — | — | EP | claimed |
| US-4281198-A | REACTING TRIMETHYLANILINIUM HALIDE WITH HYDRAZINE OR MONOMETHYLHYDRAZINE | JAPAN HYDRAZINE CO., INC. (JP) | 1981-07-28 | — | — | US | claimed |
| EP-0010843-A1 | Method of making 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide | UNIROYAL LTD. (CA) | 1980-05-14 | — | — | EP | claimed |
| US-4182716-A | Method of making 5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide | UNIROYAL, LTD. (CA) | 1980-01-08 | — | — | US | claimed |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12606513-B2 | Formate production method, formic acid production method, and antifreezing agent production method | NITTO DENKO CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-4008219-A | CNS ANALGESIC, ANTITUSSIVE, SEDATIVE | NIHON IYAKUHIN KOGYO CO., LTD. (JA) | 1977-02-15 | — | — | US | disclosed |
| US-4003749-A | Heat-developable light-sensitive materials using the reaction product of a organic silver salt an a N-halo-oxazolidinone | FUJI PHOTO FILM CO., LTD. (JA) | 1977-01-18 | — | — | US | disclosed |
| US-4002479-A | ORGANIC SILVER SALT, SILVER HALIDE, AND A REDUCING AGENT | FUJI PHOTO FILM CO., LTD. (JA) | 1977-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606513-B2 | Formate production method, formic acid production method, and antifreezing agent production method | CA2, TAF5, HACL2 | CYP3A4 1600/4885TSHR 2160/4885PIK3CA 3911/4885 |
| US-20260118767-A1 | REVERSE PATTERNING PROCESS | EFNA1, EPHA4, ETV6 | CYP3A4 3527/4885TSHR 770/4885PIK3CA 422/4885 |
| US-20110224458-A1 | PREPARATION OF METHIONINE OR SELENOMETHIONINE FROM HOMOSERINE VIA A 4-SUBSTITUTED 2-AMINOBUTANOIC ACID INTERMEDIATE | MTR, CBS, ABAT | CYP3A4 646/4885TSHR 2605/4885PIK3CA 3133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.